| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Mitochondrial long chain fatty acid betaoxidation 0.7694924567576847 2.6005102026227904 0.0093085251038371 0.996274550870344 0.588665319462229 13 P40939,P23786,P11310,O43772,Q16836 5 |
| Fatty acid betaoxidation 0.6898424273956181 2.54647471872913 0.0108817093355613 0.9985597321996098 0.588665319462229 19 P23786,Q16836,O43772 3 |
| Ppar signaling pathway 0.7025919452823869 2.4433099856098615 0.0145532309958298 0.9998441755482838 0.6216308668218745 15 P11310,P23786,Q15067 3 |
| Ciliopathies 0.7189248689446578 2.346104120443444 0.0189708070991212 0.9999893880603364 0.6632932423433882 13 Q10713,O43924,Q13432 3 |
| Pathogenic escherichia coli infection 0.6167594557581827 2.3231286576909898 0.0201722418831216 0.9999949003105556 0.6632932423433882 23 Q9BUF5,Q13885,Q9BVA1,P07437,P68371 5 |
| Novel intracellular components of rigilike receptor rlr pathway 0.7315745514037233 2.152944141622307 0.0313230687770182 0.999999994567291 0.758105718382072 11 O00571,Q7Z434,Q92841,Q13546,Q14790 5 |
| Disruption of postsynaptic signaling by cnv 0.7940587805052 2.075122586260915 0.0379751749361514 0.999999999911815 0.758105718382072 7 Q14168,Q13555,Q06787 3 |
| Eicosanoid metabolism via cyclooxygenases cox 0.8634368571369624 2.0471976448316456 0.0406386825942575 0.999999999983198 0.758105718382072 5 O15254,Q8N8N7,Q15067 3 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7871052993428891 2.0452396939476354 0.0408312329047799 0.9999999999850986 0.758105718382072 7 Q14739,Q15392 2 |
| Ketogenesis and ketolysis 0.8249237707730572 2.0447109852159775 0.0408833599696478 0.9999999999855752 0.758105718382072 6 P23786,O43772 2 |
| Mecp2 and associated rett syndrome 0.6196889083741636 2.019758303484516 0.04340846414762 0.9999999999970184 0.758105718382072 16 P31943,P35637,Q05086,P52597 4 |
| Pparalpha pathway 0.8176678389121838 2.014839644319125 0.043921453665247 0.9999999999978364 0.758105718382072 6 P23786 1 |
| Joubert syndrome 0.6013551056601149 1.9869275164773743 0.046930429824687 0.9999999999996716 0.758105718382072 18 Q10713,O43924,Q13432,Q15154 4 |
| Alzheimers disease and mirna effects 0.4651950919006297 1.959336949395456 0.0500733392773076 0.9999999999999544 0.758105718382072 83 P31751,Q13885,Q9BVA1,P28070,P49721,P42345,P60900,P07437,P68371,Q14790,P49720,P28072,P25788,P20618,Q99436,P28074,P45880,Q96IX5,Q9BUF5 19 |
| Cardiac hypertrophic response 0.7047599987722931 1.955635758851131 0.0505080773273944 0.9999999999999654 0.758105718382072 10 P42345,P36507,P31751,P46734 4 |
| Tryptophan metabolism 0.6161726961723912 1.9356091735937375 0.0529155859750218 0.9999999999999925 0.758105718382072 14 P40939,P35610,P05091,Q16836,Q15392 5 |
| Alzheimers disease 0.4598854659968804 1.930367138710935 0.0535613636013854 0.999999999999995 0.758105718382072 81 P28072,P25788,P20618,Q99436,P28070,Q9BUF5,P31751,Q13885,P28074,P49721,P42345,Q9BVA1,P45880,P60900,P07437,P68371,Q14790,P49720 18 |
| Tolllike receptor signaling pathway 0.6589557574764148 1.9094549666547729 0.0562034258033026 0.999999999999999 0.758105718382072 12 Q16539,P36507,P31751,P46734,Q13546,Q14790 6 |
| Mapk cascade 0.7722694525008243 1.825768694923431 0.0678851106644851 1.0 0.758105718382072 6 P46734,P36507,P62993 3 |
| Influence of laminopathies on wnt signaling 0.6622552667338003 1.8131881598759536 0.0698028053730313 1.0 0.758105718382072 11 P50402,O75844,P48729,O60725 4 |
| Cytosine methylation 0.8710781857762782 1.808990101918513 0.0704525411009986 1.0 0.758105718382072 4 P48735 1 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.7676976438687577 1.8065262056127969 0.0708361845833061 1.0 0.758105718382072 6 Q16539,Q7Z434,Q13546 3 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.6920425016989973 1.7759160108809862 0.0757467615688927 1.0 0.758105718382072 8 P31751,Q05086 2 |
| 7oxoc and 7betahc pathways 0.67807989797803 1.7666188149083262 0.0772920878413836 1.0 0.758105718382072 9 O15118,Q15125 2 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.7228207008067862 1.7642893688863022 0.0776832729259968 1.0 0.758105718382072 7 P42345,P36507,P46734 3 |
| 15q112 copy number variation syndrome 0.857467264536359 1.7566291551570803 0.0789810401379411 1.0 0.758105718382072 4 Q96CW5,Q06787 2 |
| Proteasome degradation 0.4934839569876467 1.752427434544676 0.0797003374625939 1.0 0.758105718382072 41 P28072,P49720,P20618,P28070,P28074,P49721,P60900,Q9UL46 8 |
| Circadian rhythm genes 0.4977554564764406 1.7210701319449224 0.0852380984120286 1.0 0.758105718382072 38 P63208,P00813,P11802,P17844,P43490,P54802,Q15233,Q9BQ04,Q06210,Q05086,Q9BWF3,O14744,Q00839,P23246,Q14103 15 |
| Vitamin b12 metabolism 0.6790214812043649 1.715158507642414 0.0863161698238266 1.0 0.758105718382072 8 Q96EY8 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5770714885221261 1.714283264450638 0.0864767152018879 1.0 0.758105718382072 14 P50402,O75844,Q9UPY3,P48729,O60725,P42166 6 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.739775837379465 1.6882438743064767 0.0913644242343625 1.0 0.758105718382072 6 Q8IXH7 1 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.7036438747942009 1.6789137178858444 0.0931688606353995 1.0 0.758105718382072 7 Q16539,Q13555,P42224 3 |
| Lung fibrosis 0.7621790397391568 1.6396339039327477 0.101081309298354 1.0 0.758105718382072 5 O95453 1 |
| 1q211 copy number variation syndrome 0.6945355104425607 1.638129181839043 0.1013947486718482 1.0 0.758105718382072 7 Q9NPH0 1 |
| Kennedy pathway from sphingolipids 0.822572470334052 1.6214342444973926 0.1049245415159902 1.0 0.758105718382072 4 P35790 1 |
| Genes related to primary cilium development based on crispr 0.6458380790201463 1.6117440441170028 0.1070176490783381 1.0 0.758105718382072 9 Q10713,P63167,A0AVF1,O95684 4 |
| Dna mismatch repair 0.5356878861072263 1.588410823346008 0.1121934716227561 1.0 0.758105718382072 18 P15927,P41440,Q9UQ84,Q9NR33 4 |
| Cohesin complex cornelia de lange syndrome 0.5446768827519123 1.5804119647869106 0.114012553284662 1.0 0.758105718382072 16 Q7Z5K2,Q29RF7 2 |
| Caloric restriction and aging 0.8115929148867431 1.578638048136728 0.1144191022582625 1.0 0.758105718382072 4 P43490 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.5906232752608844 1.5517659716749954 0.1207182308166023 1.0 0.758105718382072 12 Q32P28,P13674,Q96AY3 3 |
| Mitochondrial complex i assembly model oxphos system 0.497570781673836 1.5389724445708932 0.1238110235115532 1.0 0.758105718382072 23 Q96CU9,Q16718,O43676,O96000,O95168,O75306,Q7L592 7 |
| Folate metabolism 0.5361054182111205 1.502115620025 0.1330672515401256 1.0 0.758105718382072 15 Q8WTV0,P00374,P34897,P41440 4 |
| Ethanol effects on histone modifications 0.6192526694858397 1.4824717657604105 0.1382148107904131 1.0 0.758105718382072 9 P41440,P05091 2 |
| Sphingolipid metabolism integrated pathway 0.6596684195119067 1.4807276802565263 0.1386791547454153 1.0 0.758105718382072 7 Q06136,P27544 2 |
| Sphingolipid metabolism overview 0.6596684195119067 1.4807276802565263 0.1386791547454153 1.0 0.758105718382072 7 Q06136,P27544 2 |
| Adipogenesis 0.5312107470821849 1.473147358187466 0.1407113059648725 1.0 0.758105718382072 15 O75844,P14174,Q9NZ45,P43490 4 |
| Kisspeptinkisspeptin receptor system in the ovary 0.7108481629784658 1.4276883783797454 0.1533815727007663 1.0 0.7788320583955642 5 P31751 1 |
| Apoptosis modulation by hsp70 0.6168264334650405 1.4204020403690676 0.1554906691471891 1.0 0.781373278571589 8 O95831,Q13546 2 |
| Serotonin htr1 group and fos pathway 0.6001688385821166 1.3889232307420778 0.164856095582945 1.0 0.8038576472265766 9 P46734,P36507 2 |
| Alpha 6 beta 4 signaling pathway 0.6672801133087313 1.3758103028845587 0.1688803708534734 1.0 0.8038576472265766 6 P42345,P62993 2 |
| Thermogenesis 0.4733385233951719 1.372787661317998 0.1698183676732099 1.0 0.8038576472265766 23 P23786,O43772,P42345,P46734,P62993 5 |
| Erbb signaling pathway 0.5176946909680709 1.3698973989737002 0.1707189317688549 1.0 0.8038576472265766 14 P42345,P31751,Q13555,P62993 4 |
| Praderwilli and angelman syndrome 0.662093996129258 1.3532259744195114 0.1759834496518848 1.0 0.8157992472234662 6 Q7L576,Q05086,Q15154 3 |
| Metapathway biotransformation phase i and ii 0.4778477609011946 1.3236445526023326 0.1856211212717555 1.0 0.8422290251317289 21 Q86UY6 1 |
| Familial partial lipodystrophy fpld 0.6243531146036247 1.31956253935615 0.1869811169320256 1.0 0.8422290251317289 7 O75844,O60725 2 |
| Head and neck squamous cell carcinoma 0.5283243452146977 1.318378522413151 0.1873769668661484 1.0 0.8422290251317289 13 P42345,P31751,P62942 3 |
| Glycerolipids and glycerophospholipids 0.6789364090881349 1.2947144224055005 0.1954187628087194 1.0 0.8529957675884249 5 Q9HCL2 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7349624262540686 1.2775640474892007 0.2014031840497878 1.0 0.8664683745451305 4 Q16539,P07099 2 |
| Eukaryotic transcription initiation 0.4951140745976389 1.2579986505326055 0.2083922442861268 1.0 0.875831174147215 15 P13984,P29083,P19447 3 |
| Onecarbon metabolism and related pathways 0.5513015663117193 1.2461032401568222 0.2127264954444578 1.0 0.8773134087985228 11 P34896,P34897,P48507,P35790,O43865 5 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.6349680267548982 1.2347812042133826 0.2169119444254303 1.0 0.8773629917094121 6 Q16539,P36507 2 |
| Ranklrank signaling pathway 0.546500430900693 1.221115414927357 0.222042324017627 1.0 0.8773629917094121 11 Q16539,P42345,P31751 3 |
| Nrf2are regulation 0.6253665689149562 1.1927703682492032 0.2329593180209825 1.0 0.8773629917094121 6 P09601,Q13155,Q96HS1,P49841,P48507 5 |
| Parkinubiquitin proteasomal system pathway 0.4325528803550943 1.190493837907655 0.2338523505316592 1.0 0.8773629917094121 37 P07437,Q9BVA1,P68371,Q13885 4 |
| Omega3 omega6 fatty acid synthesis 0.6247445930279842 1.1900481207059457 0.2340274791774637 1.0 0.8773629917094121 6 Q15067 1 |
| Insulin signaling in adipocytes diabetic condition 0.7114200735032152 1.1847041091907 0.2361344572059871 1.0 0.8773629917094121 4 P31751 1 |
| Insulin signaling in adipocytes normal condition 0.7114200735032152 1.1847041091907 0.2361344572059871 1.0 0.8773629917094121 4 P31751 1 |
| Mthfr deficiency 0.5869586308659459 1.1476928442402434 0.2510953862632012 1.0 0.8891620597763752 7 Q7L592,P35790 2 |
| Energy metabolism 0.5512352072812975 1.1470399730441456 0.2513651006777953 1.0 0.8891620597763752 9 Q16539,Q96EB6,Q15648,Q99873,Q9BQG0,Q13555 6 |
| Nocgmppkg mediated neuroprotection 0.614374250382733 1.1446531666352897 0.2523528590068487 1.0 0.8891620597763752 6 Q13555 1 |
| Congenital generalized lipodystrophy cgl 0.8631039531478784 1.1092693345080986 0.2673140098595679 1.0 0.9063724389611292 2 P31751 1 |
| Dna replication 0.4281342559323834 1.0958381487338174 0.2731496104597268 1.0 0.9176599272748126 25 Q9Y619,P15927,P41440 3 |
| Pyrimidine metabolism 0.4196277001767767 1.087777956457451 0.2766931431590906 1.0 0.9243715061962916 37 Q9NR33,Q9H773,Q14181,P31350,P32321 5 |
| Mirna regulation of prostate cancer signaling pathways 0.5362616055428118 1.0727521794848194 0.283382321854329 1.0 0.9260252921797198 9 P42345,P62993 2 |
| Target of rapamycin tor signaling 0.5699040202270144 1.0691731260134592 0.284991665779386 1.0 0.9260664093678636 7 P42345,P62942 2 |
| Nucleotide excision repair 0.4281042411875381 1.059285860526469 0.2894696123872804 1.0 0.9281186089625938 23 P19447,Q9NR33,P15927,Q9NRF9,P18074,P41440 6 |
| Oxysterols derived from cholesterol 0.5352632693054935 1.0264293778654654 0.3046892363280697 1.0 0.9322721601969288 8 Q15125 1 |
| Kallmann syndrome 0.8181918440161133 1.0017849158258838 0.3164474840117761 1.0 0.9322721601969288 3 P62993 1 |
| Exrna mechanism of action and biogenesis 0.833821376281118 0.9964692394689668 0.3190222056966041 1.0 0.9322721601969288 2 Q9HAV4 1 |
| Sphingolipid pathway 0.5284727516583625 0.993572357536278 0.3204311073224879 1.0 0.9322721601969288 8 Q06136 1 |
| Sars coronavirus and innate immunity 0.830893118594435 0.9852880300055448 0.324482610687792 1.0 0.9373942086536216 2 Q7Z434 1 |
| Histone modifications 0.6015697999667057 0.9717501264014656 0.3311748728326682 1.0 0.94757212418151 5 Q8IYR2,Q9H7B4 2 |
| Camkk2 pathway 0.5023690663632804 0.9460215510320164 0.3441375942664444 1.0 0.9709358180432048 10 Q9Y3D6,O00429,Q96EB6,P09601,P42345,O76024 6 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.4923364077133724 0.9389132707815196 0.3477752750774423 1.0 0.9718206284874324 11 Q13546,P31751,Q14790 3 |
| Hedgehog signaling pathway wp4249 0.6456309707128025 0.9269277147778672 0.3539640664127037 1.0 0.9805331402823472 4 P48729 1 |
| Disorders of folate metabolism and transport 0.5374759320133431 0.920292825814326 0.3574197570933526 1.0 0.9805331402823472 7 P00374,P34897 2 |
| Methionine de novo and salvage pathway 0.5374624872143241 0.9202313391899416 0.3574518805711566 1.0 0.9805331402823472 7 Q13126 1 |
| Nanoparticle triggered regulated necrosis 0.7927774770054643 0.9117117388709514 0.3619204827994351 1.0 0.9882577566852156 3 Q13546 1 |
| Vitamin d in inflammatory diseases 0.7913554936703483 0.9067098505983764 0.364560252893237 1.0 0.9909410510461624 3 P46734 1 |
| Embryonic stem cell pluripotency pathways 0.4695307868255966 0.8984530924830089 0.3689440422266772 1.0 0.991574144381256 12 P42345,P31751,P46734,P62993 4 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4079980041541307 0.8876258053260616 0.3747420679434179 1.0 0.991574144381256 22 Q14739,Q15392 2 |
| Male infertility 0.4262441243666793 0.8805846124958595 0.378542690097126 1.0 0.9959742799659862 17 P34896,Q15165,P41440,P18074 4 |
| Interleukin1 il1 structural pathway 0.4911984382351898 0.8500775742311594 0.3952819587396854 1.0 0.9959742799659862 9 P46734,P36507 2 |
| Hepatitis b infection 0.4022481469046642 0.8487888219521019 0.3959988112050348 1.0 0.9959742799659862 22 Q16539,O00571,P36507,P31751,P46734,P62993,Q7Z434,Q14790 8 |
| Wnt signaling 0.4432698519995677 0.8387150074649775 0.401629254711219 1.0 0.9959742799659862 13 Q8TAA9,Q13555,Q13363 3 |
| P38 mapk signaling pathway 0.5173673227800815 0.8286997246365349 0.4072743416359214 1.0 0.9959742799659862 7 Q16539,Q13546,P62993 3 |
| Ccl18 signaling pathway 0.4768731359764347 0.8174913569482657 0.4136476865683474 1.0 0.9959742799659862 10 P07196,P08670,P00403,P42224 4 |
| Neuroinflammation 0.764188941779568 0.8120952432874546 0.4167369824058387 1.0 0.9959742799659862 3 Q16539,P42345 2 |
| Micrornas in cardiomyocyte hypertrophy 0.4141924388929265 0.7894001154972478 0.4298781884174452 1.0 0.9959742799659862 16 Q16539,P31751,P42345,P46734,Q9P2K5,P36507 6 |
| Cytosolic dnasensing pathway 0.4614049794749471 0.7792875017811761 0.4358103753125211 1.0 0.9959742799659862 11 Q13546,Q14790 2 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.447238720660245 0.7790169203099224 0.4359697475851318 1.0 0.9959742799659862 12 Q7Z434,Q13546,Q14790 3 |
| Type i interferon induction and signaling during sarscov2 infection 0.7399110247434664 0.7293670606850394 0.4657771611765819 1.0 0.9959742799659862 3 Q7Z434 1 |
| Nucleotidebinding oligomerization domain nod pathway 0.4934526258171452 0.7211156486447422 0.4708383638291518 1.0 0.9959742799659862 7 Q9P0J0,Q14790 2 |
| Sphingolipid metabolism in senescence 0.4568511155334542 0.717827482576301 0.4728636656697618 1.0 0.9959742799659862 10 Q96G23,Q06136 2 |
| G protein signaling pathways 0.4278642768954139 0.6767519014330925 0.498563380166181 1.0 0.9959742799659862 12 O43823 1 |
| Nanoparticlemediated activation of receptor signaling 0.4802755485530023 0.6627252565557565 0.5075065310140785 1.0 0.9959742799659862 7 P36507,P62993 2 |
| Mirna biogenesis 0.718646941801393 0.6586850803059535 0.5100980156281105 1.0 0.9959742799659862 3 Q9HAV4 1 |
| Glioblastoma signaling pathways 0.4104140691110033 0.6574741332970847 0.5108760978581319 1.0 0.9959742799659862 13 P46734,P31751,P36507,P62993 4 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.716953496887587 0.6531376590888296 0.5136675359691845 1.0 0.9959742799659862 3 Q13155,P48507 2 |
| Preimplantation embryo 0.4567463625041746 0.6519625440615009 0.5144253356778763 1.0 0.9959742799659862 8 Q99729,Q92945,Q99626 3 |
| Progeriaassociated lipodystrophy 0.4486876640028348 0.6445107224960571 0.5192443068111392 1.0 0.9959742799659862 9 O60725 1 |
| Nitric oxide metabolism in cystic fibrosis 0.5201753359336234 0.6417104442382306 0.5210612065975626 1.0 0.9959742799659862 5 Q86X55,O14744 2 |
| Amino acid metabolism pathway excerpt histidine catabolism extension 0.7313323572474348 0.6226980430109594 0.5334829689825566 1.0 0.9959742799659862 2 Q8TD30 1 |
| Follicle stimulating hormone fsh signaling pathway 0.4695978722914855 0.6160062477634172 0.5378903962947295 1.0 0.9959742799659862 7 P42345 1 |
| Tnfalpha signaling pathway 0.3778303625470231 0.6030799457616607 0.5464555067607417 1.0 0.9959742799659862 18 P63208,P46734,Q13546,Q14790 4 |
| Eicosanoid metabolism via lipooxygenases lox 0.5086827796026091 0.5971084588730294 0.5504349707225575 1.0 0.9959742799659862 5 O15254,Q8N8N7,Q15067 3 |
| Tcell activation sarscov2 0.4318690474993587 0.5960343386179318 0.5511522872023731 1.0 0.9959742799659862 10 P42345,P62993 2 |
| Epithelial to mesenchymal transition in colorectal cancer 0.3700688241847495 0.5908627674115199 0.5546123747227178 1.0 0.9959742799659862 20 Q15022,P31751,Q16625,P46734,P62993,P36507 6 |
| Serine metabolism 0.4814529840891075 0.576218600772703 0.5644674340845399 1.0 0.9959742799659862 6 P00374,P34897 2 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.4201716567653452 0.5403524953163791 0.5889539621100532 1.0 0.9959742799659862 10 P31751 1 |
| Network map of sarscov2 signaling pathway 0.3475000213580889 0.5363180477501901 0.5917387594861081 1.0 0.9959742799659862 24 Q99829,P42345,P31350,Q7Z434,Q96J02,Q14790 6 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3688736350308306 0.5360994865103529 0.5918897949960105 1.0 0.9959742799659862 17 P50402,Q14739,P42166,P62993 4 |
| Triacylglyceride synthesis 0.6782483840763486 0.5302193598839715 0.595959849649419 1.0 0.9959742799659862 3 Q9HCL2 1 |
| Integrinmediated cell adhesion 0.3600713140914809 0.52928038406594 0.5966109611370327 1.0 0.9959742799659862 20 P04632,P31751,P46734,P62993 4 |
| Translation factors 0.3457179715497437 0.506833329538806 0.6122717683923264 1.0 0.9959742799659862 36 O75153 1 |
| Fluoropyrimidine activity 0.4064300241584816 0.5058288283047099 0.6129768189041145 1.0 0.9959742799659862 11 P31350,P00374,P18074 3 |
| Bladder cancer 0.4797966368849101 0.4885120518630478 0.6251871912894691 1.0 0.9959742799659862 5 P36507 1 |
| Estrogen receptor pathway 0.6632191820992078 0.4847827278813305 0.6278304759757971 1.0 0.9959742799659862 3 Q15067 1 |
| Resistin as a regulator of inflammation 0.4766086399366958 0.4768843765710789 0.6334444577941487 1.0 0.9959742799659862 5 P31751 1 |
| Glycerophospholipid biosynthetic pathway 0.454065041927152 0.468008059324135 0.6397788263248039 1.0 0.9959742799659862 6 P48651,Q9HCL2 2 |
| Nanomaterial induced apoptosis 0.4151092674641424 0.4644141005917352 0.6423510895571798 1.0 0.9959742799659862 8 O95831 1 |
| Proteoglycan biosynthesis 0.6523560375194617 0.4528631853468551 0.6506472617832035 1.0 0.9959742799659862 3 Q8TB61 1 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.3695455322506784 0.4428045150964945 0.6579071372292538 1.0 0.9959742799659862 13 P48729,Q13363,Q00839,P61978 4 |
| Glutathione metabolism 0.4671056503982655 0.4427051563233237 0.6579790123368097 1.0 0.9959742799659862 5 O75874,P48507 2 |
| Modulators of tcr signaling and t cell activation 0.4037768218036692 0.4385011818242217 0.6610230136297575 1.0 0.9959742799659862 9 Q14344,O96000 2 |
| Tcell receptor tcr signaling pathway 0.3538787556460219 0.4265551341211548 0.6697033822662757 1.0 0.9959742799659862 14 P08670,P36507,P62993 3 |
| Wnt signaling pathway 0.3774143033388433 0.4228123646207114 0.6724321656721084 1.0 0.9959742799659862 12 Q13363,P42345 2 |
| Cardiac progenitor differentiation 0.666178623718895 0.4156527800444691 0.6776640990018097 1.0 0.9959742799659862 2 Q16539 1 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.6369802776996272 0.4091236463644619 0.6824489238543845 1.0 0.9959742799659862 3 P48507 1 |
| Interactome of polycomb repressive complex 2 prc2 0.5013006049758715 0.4063901767768348 0.6844559362617 1.0 0.9959742799659862 4 Q15022 1 |
| Mitochondrial fatty acid synthesis pathway 0.6312265192257218 0.3932170983059559 0.6941591421569175 1.0 0.9959742799659862 3 Q53GQ0 1 |
| Retinoblastoma gene in cancer 0.3244399117080375 0.3783599645205034 0.7051632050989873 1.0 0.9959742799659862 41 Q9Y619,P00374,P31350 3 |
| Nuclear receptors metapathway 0.3198615858088501 0.3608099277614104 0.7182415407629235 1.0 0.9959742799659862 43 P23786,Q9HCL2,Q15067 3 |
| G1 to s cell cycle control 0.3249243780506846 0.3522864870711558 0.7246234211741447 1.0 0.9959742799659862 22 Q9Y619,P15927 2 |
| Allograft rejection 0.3599265243489984 0.3412383156057374 0.7329241807645532 1.0 0.9959742799659862 12 P08670,Q9BY49,Q14790 3 |
| Orexin receptor pathway 0.3347516613697661 0.3296295865346652 0.7416798641346567 1.0 0.9959742799659862 14 P31350,O60313,Q13595,P50336 4 |
| Sarscov2 and covid19 pathway 0.6068484994728651 0.3288420479727472 0.7422750792327686 1.0 0.9959742799659862 3 Q8WTV0 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.4740806235374461 0.3236409512440525 0.7462098805713997 1.0 0.9959742799659862 4 P48729,P25054 2 |
| Translation inhibitors in chronically activated pdgfra cells 0.3277042194087309 0.3104260025011663 0.7562370229994086 1.0 0.9959742799659862 17 P42345,P36507,P31751,P46734 4 |
| Nucleotide excision repair in xeroderma pigmentosum 0.3169137435253156 0.3082595715223493 0.7578848263427673 1.0 0.9959742799659862 30 P19447,Q9NR33,P15927,Q9NRF9,P18074,P41440 6 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.376725377394099 0.3055903459901678 0.7599165718528753 1.0 0.9959742799659862 8 Q9NR77 1 |
| Statin inhibition of cholesterol production 0.4261182169567299 0.3049595898431003 0.7603969298063702 1.0 0.9959742799659862 5 P35610,Q8WTV0 2 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.3659475142738495 0.2995808384071898 0.7644969019645322 1.0 0.9959742799659862 10 Q16539,P42345,P36507 3 |
| Angiopoietinlike protein 8 regulatory pathway 0.3110454693233806 0.2974695478712096 0.7661080535948923 1.0 0.9959742799659862 25 P31751,P42345,P46734,P41440,P36507 5 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3900319868554962 0.2949417705211072 0.7680383622346012 1.0 0.9959742799659862 7 P42345,Q13418,P49770 3 |
| Apoptosis modulation and signaling 0.3221160873746133 0.2764451153590151 0.7822062091817259 1.0 0.9959742799659862 16 O95831,P04632,Q13546 3 |
| Egfr tyrosine kinase inhibitor resistance 0.3447476913576667 0.2742001892676439 0.783930782677458 1.0 0.9959742799659862 12 P42345,P31751,P62993 3 |
| Signal transduction through il1r 0.4137665794880775 0.2670688536536371 0.7894161480331703 1.0 0.9959742799659862 5 P46734 1 |
| Breast cancer pathway 0.3111046823323181 0.2605583110306835 0.7944331423162714 1.0 0.9959742799659862 21 P63208,P48729,P31751,P42345,P62993,P36507 6 |
| Onecarbon metabolism 0.325839037512153 0.2374143688251682 0.8123353436440133 1.0 0.9959742799659862 13 P34896,P00374,P34897 3 |
| Ebola virus infection in host 0.3064450205775805 0.2340903267001471 0.8149148554994761 1.0 0.9959742799659862 36 P41440 1 |
| Dna damage response 0.3011902413191724 0.2085433848235159 0.8348047110107468 1.0 1.0 21 Q9Y3B8,P15927,P41440 3 |
| Oxidation by cytochrome p450 0.3913840326219541 0.2034308045183165 0.8387983246368913 1.0 1.0 5 Q16850 1 |
| Transsulfuration and onecarbon metabolism 0.3054486259772619 0.2018625164994665 0.8400242062938967 1.0 1.0 17 P34896,P00374,P34897,P48507,O43865 5 |
| Insulin signaling 0.3008932707985741 0.2014405951508845 0.8403540753856675 1.0 1.0 33 P31751,P46976,P42345,P46734,P41440,P62993,P36507 7 |
| Mirna regulation of dna damage response 0.2972227733783256 0.1984563918569225 0.8426880003843931 1.0 1.0 22 Q9Y3B8,P15927,P41440 3 |
| Sterol regulatory elementbinding proteins srebp signaling 0.2970434253992544 0.1923206152138563 0.8474910712031511 1.0 1.0 29 O95487,Q13907,P48449,Q9HCL2,Q16850,Q8WTV0,Q14534,P42345 8 |
| Fragile x syndrome 0.2998125356493756 0.1922036829829995 0.8475826610866433 1.0 1.0 36 Q7L576,P53985,Q9UPY3,P42345,P28288,P62993,P36507,Q06787 8 |
| Physiological and pathological hypertrophy of the heart 0.354521091926458 0.1754959127897074 0.8606899820657605 1.0 1.0 7 P46734,Q9P2K5 2 |
| Hippo signaling regulation pathways 0.3072399852995243 0.1612515890751116 0.8718952505087718 1.0 1.0 13 Q13043,P60953,P13861,P42345,P63000,P17612,P04899,Q9NWH9,P08754,P10644,P35222,P61586 12 |
| Oncostatin m signaling pathway 0.2955691598965215 0.1541125368695031 0.877521003382244 1.0 1.0 15 Q16539,P42345,P36507,P62993 4 |
| Imatinib and chronic myeloid leukemia 0.5225192237275722 0.1501540535392534 0.8806430747901042 1.0 1.0 3 P08183,P46087 2 |
| Interferon type i signaling pathways 0.2914362721521026 0.1376015571245512 0.8905553248294444 1.0 1.0 14 Q16539,P42345,Q99873,P46734 4 |
| Melatonin metabolism and effects 0.3868131868131887 0.1161382075261639 0.907543008454098 1.0 1.0 4 P49841,Q96EB6,P19838 3 |
| Amyotrophic lateral sclerosis als 0.3136184618640278 0.1091106791154995 0.9131147047535036 1.0 1.0 10 Q16539,P36507,P07196 3 |
| Purinergic signaling 0.4891980959355547 0.1005288766185092 0.9199244587264616 1.0 1.0 3 P08754,P63096 2 |
| Endometrial cancer 0.2991867940629688 0.1001430013266299 0.9202307967762716 1.0 1.0 12 P31751,P62993 2 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.3116892263774937 0.0940257397151172 0.925088709974588 1.0 1.0 9 O43683 1 |
| Heme biosynthesis 0.3439137532802725 0.0927860826601515 0.926073507737776 1.0 1.0 5 P36551 1 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.3707393469860204 0.0890542531800847 0.9290387935526538 1.0 1.0 4 P11802 1 |
| Supression of hmgb1 mediated inflammation by thbd 0.5036603221083538 0.0872832303514506 0.9304463833851364 1.0 1.0 2 P09429 1 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.5036603221083509 0.0872832303514475 0.9304463833851389 1.0 1.0 2 P28482 1 |
| Ltf danger signal response pathway 0.5036603221083509 0.0872832303514475 0.9304463833851389 1.0 1.0 2 P28482 1 |
| Neovascularisation processes 0.5036603221083509 0.0872832303514475 0.9304463833851389 1.0 1.0 2 P28482 1 |
| Lipid metabolism pathway 0.3067889908256893 0.0800547513565978 0.9361937103747104 1.0 1.0 9 P08559,Q13085,P53396,P49327,P31751,P13861,P17612,P10644 8 |
| Hypertrophy model 0.4901171303074784 0.0737874324304864 0.9411795272314152 1.0 1.0 2 P06730 1 |
| Map3k1 role in promoting and blocking gonadal determination 0.3586080586080607 0.0710066337535664 0.943392475848079 1.0 1.0 4 P49841,P28482,P61586 3 |
| Mitochondrial gene expression 0.3487472140475001 0.0578296999329447 0.9538842806341076 1.0 1.0 4 Q9P2K5 1 |
| Osteopontin signaling 0.4503844745514464 0.0576765306473082 0.9540062883987142 1.0 1.0 3 P19838,P28482 2 |
| Hepatitis c and hepatocellular carcinoma 0.2951603226950566 0.0554106543556184 0.9558113079312052 1.0 1.0 10 P31350,P62993 2 |
| Tgfbeta signaling pathway 0.2709880284594692 0.0504741878783161 0.9597445182684636 1.0 1.0 30 P63208,Q9NPI6,P46734,P62993,Q96J02,P36507 6 |
| Il1 signaling pathway 0.290148316632292 0.0493644727564675 0.9606288402605744 1.0 1.0 11 P46734,P36507 2 |
| Common pathways underlying drug addiction 0.3061972863953064 0.0476576681476605 0.9619890716667454 1.0 1.0 7 P63096,P28482,P62140,P17612,P36507,Q02750 6 |
| Mrna processing 0.2903955114048055 0.0228703262557384 0.9817537104197244 1.0 1.0 98 P08621,P22626,P84103,P62995,P38159,Q13242,Q14562,P07910,Q05048,O75494,O60231,Q9UPY3,O75533,Q99873,P14866,P09651,O43143,P61978,Q7RTV0,P31943,Q00839,Q15233,O43390,Q99729,P52272,P35637,P55795,Q14103 28 |
| Nonhomologous end joining 0.3917978762358112 0.0193340303147832 0.9845746367320138 1.0 1.0 3 P12956,P78527 2 |
| Transsulfuration pathway 0.2921145666546054 0.0189158033235826 0.9849082725674638 1.0 1.0 7 P48507,Q99707 2 |
| Folatealcohol and cancer pathway hypotheses 0.2679355783308835 0.0147530578987655 0.9882291898709614 1.0 1.0 2 Q99707 1 |
| Dna repair pathways full network 0.2672198154182609 0.0141136382489285 0.988739319790459 1.0 1.0 44 P19447,Q9NR33,P15927,Q9NRF9,Q9UQ84,P13051,P41440 7 |
| Small cell lung cancer 0.2750872045079728 0.0107953942889051 0.9913866888694134 1.0 1.0 11 P63208,P31751,Q14790 3 |
| Hair follicle development cytodifferentiation part 3 of 3 0.3584767484437934 0.0082089943795427 0.9934502436869754 1.0 1.0 3 Q9BZE4,P19838 2 |
| Striated muscle contraction pathway 0.2852951961862829 0.0064197834727485 0.9948777890675632 1.0 1.0 7 P28289,P09493,P08670,O43707,P35609,P06753 6 |
|
|
